✦ LIBER ✦

Drug eluting stents: Case study in the acceptance of a new medical technology

✍ Scribed by Lloyd W. Klein; John McB. Hodgson

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 60 KB
Volume: 64
Category: Article
ISSN: 1522-1946
DOI: 10.1002/ccd.20367

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Determinants of embolic protection devic

Determinants of embolic protection device use: Case study in the acceptance of a new medical technology

✍ Michael J. Lim; John J. Young; Shaun R. Senter; Lloyd W. Klein; for Intervention 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 2 views

Defining a new standard for IVUS optimiz

Defining a new standard for IVUS optimized drug eluting stent implantation: The PRAVIO study

✍ R.T. Gerber; A. Latib; A. Ielasi; J. Cosgrave; A. Qasim; F. Airoldi; A. Chieffo; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB 👁 1 views

## Abstract ## Objectives: Preliminary Investigation to the Angiographic Versus IVUS Optimization Trial is a single center prospective observational intravascular ultrasound (IVUS) guided stent implantation study assessing new criteria for optimal drug eluting stent (DES) deployment. ## Backgroun

Outcome in the real-world of coronary hi

Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID)—A single-center study comparing Cypher™ sirolimus-eluting with Taxus™ paclitaxel-eluting stents

✍ S. Kumar; V. Suresh; B.D. Prendergast; N.H. Brooks; P. Wicks; R.D. Levy; S.G. Ra 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Outcomes after differential use of drug-

Outcomes after differential use of drug-eluting stents in diabetic patients: 1-Year results from the DES.DE (Drug-Eluting Stent.DEutschland) registry

✍ Ibrahim Akin; Alexander Bufe; Lars Eckardt; Holger Reinecke; Gert Richardt; Karl 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 2 views

First-in-human implantation of a fully b

First-in-human implantation of a fully bioabsorbable drug-eluting stent: The BVS poly-L-lactic acid everolimus-eluting coronary stent

✍ John A. Ormiston; Mark W.I. Webster; Guy Armstrong 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views

## Abstract The first‐in‐human fully bioabsorbable drug‐eluting stent (BVS poly‐L‐lactic acid everolimus‐eluting coronary stent) implantation was performed at Auckland City Hospital, New Zealand as part of the ABSORB trial. There were no adverse events in‐hospital or by 1 month. A stent that suppor

Defining a new standard for IVUS optimiz

Defining a new standard for IVUS optimized drug-eluting stent implantation—The PRAVIO study: Do we know the right technique for stent optimization?

✍ Massoud A. Leesar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB 👁 1 views